Both in Pharmaceuticals
Mannkind vs UroGen Pharma
Over the past year MNKD returned −38.0% and URGN returned +33.2%; their daily moves had a correlation of 0.16.
MNKD −38.0% URGN +33.2%Growth of $1, one year, split-adjusted
| Metric | MNKD | URGN |
|---|---|---|
| Price | $3.76 | $25.73 |
| Market cap | $1.21B | $1.26B |
| Today | −4.33% | −10.47% |
| 1 month | +9.0% | −36.8% |
| 6 months | +5.9% | −3.2% |
| Year to date | −33.7% | +9.9% |
| 1 year | −31.4% | +29.9% |
| Revenue growth (YoY) | +42.9% | +199.2% |
| Gross margin | 73.0% | 90.9% |
| Net margin | −17.4% | −19.8% |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | 6.7× |
| Net cash | -$373.9M | -$85.1M |
| Dividend yield | — | — |
| Volatility (60d) | 58.0% | 57.8% |
| Short % of float | 8.2% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).